Oculis Holding AG (OCS) reporting calendar
Oculis Holding AG files periodic reports with the SEC as OCS on Nasdaq. Atlas tracks 5 filed reports for this issuer, each linked to its original EDGAR accession.
- Next window
- 1 Apr 2026 – 20 Jun 2026
- Latest report
- 20-F
- Period ended
- 31 Dec 2025
- Filed
- 4 Mar 2026
- Reports on record
- 5
How this window is derived. Derived from this issuer's own filing history: 2 periods at a median 61-day cadence, filed a median 70 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.
Open OCS market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 20-F | 31 Dec 2025 | 4 Mar 2026 | 63 days | 0001193125-26-091446 |
| 20-F | 31 Dec 2024 | 11 Mar 2025 | 70 days | 0000950170-25-037224 |
| 20-F | 31 Dec 2023 | 19 Mar 2024 | 79 days | 0000950170-24-033144 |
| 20-F | 2 Mar 2023 | 8 Mar 2023 | 6 days | 0001193125-23-063347 |
| 20-F | 31 Dec 2022 | 28 Mar 2023 | 87 days | 0000950170-23-010352 |
Source: SEC EDGAR company submissions for CIK 0001953530. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.